Original Research
Accepted on 22 Sep 2023
Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma
Frontiers in Oncology
doi 10.3389/fonc.2023.1208403
Type at least 3 characters
2,720 articles
Articles
Review
Published on 22 Sep 2023
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
Frontiers in Oncology
doi 10.3389/fonc.2023.1184079
- 585 views
Editorial
Accepted on 21 Sep 2023
Editorial: Tumor Microenvironment Heterogeneity in Hematological Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1295996
Review
Published on 21 Sep 2023
Evolution by innovation as a driving force to improve TCR-T therapies
Frontiers in Oncology
doi 10.3389/fonc.2023.1216829
- 861 views
Review
Published on 20 Sep 2023
Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer’s disease and brain tumors
Frontiers in Oncology
doi 10.3389/fonc.2023.1265347
- 487 views
Correction
Published on 20 Sep 2023
Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study
Frontiers in Oncology
doi 10.3389/fonc.2023.1291026
- 166 views
Original Research
Accepted on 19 Sep 2023
Targeting of tumor cells by custom antigen transfer: a novel approach for immunotherapy of cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1245248
Mini Review
Published on 19 Sep 2023
Post-translational modifications and their implications in cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1240115
- 278 views
Original Research
Published on 19 Sep 2023
Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
Frontiers in Oncology
doi 10.3389/fonc.2023.1269751
- 327 views
Original Research
Accepted on 18 Sep 2023
Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study
Frontiers in Oncology
doi 10.3389/fonc.2023.1272046
Mini Review
Published on 18 Sep 2023
Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies
Frontiers in Oncology
doi 10.3389/fonc.2023.1248097
- 289 views
Original Research
Published on 13 Sep 2023
Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells
Frontiers in Oncology
doi 10.3389/fonc.2023.1228185
- 461 views
Original Research
Accepted on 12 Sep 2023
miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1166666
Review
Published on 12 Sep 2023
The multifaceted roles of matrix metalloproteinases in lung cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1195426
- 427 views
Original Research
Published on 11 Sep 2023
MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma
Frontiers in Oncology
doi 10.3389/fonc.2023.1249649
- 500 views
Review
Published on 11 Sep 2023
Progress in investigating the relationship between Schlafen5 genes and malignant tumors
Frontiers in Oncology
doi 10.3389/fonc.2023.1248825
- 255 views